Psidium guajava extract inhibits thymus and activation-regulated chemokine (TARC/CCL17) production in human keratinocytes by inducing heme oxygenase-1 and blocking NF-κB and STAT1 activation

Environmental Toxicology and Pharmacology

Volumn 32, Issue 2, 2011, Pages 136-145

  Han, Eun Hee ^a   Hwang, Yong Pil ^a   Choi, Jae Ho ^a   Yang, Ji Hye ^a   Seo, Jong Kwon ^b   Chung, Young Chul ^b   Jeong, Hye Gwang ^a  

^a Chungnam National University   (South Korea)

^b Korea International University   (South Korea)

Author keywords

Atopic dermatitis; Heme oxygenase 1; Psidium guajava; TARC

Indexed keywords

ACETIC ACID ETHYL ESTER; GAMMA INTERFERON; GUAVA EXTRACT; HEME OXYGENASE 1; HEME OXYGENASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; STAT1 PROTEIN; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG CYTOTOXICITY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME INHIBITION; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; KERATINOCYTE; PLANT LEAF; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; SKIN INFLAMMATION; TH2 CELL;

ANTI-ALLERGIC AGENTS; CELL LINE; CHEMOKINE CCL17; DERMATITIS, ATOPIC; ENZYME INDUCTION; HEME OXYGENASE-1; HUMANS; INTERFERON-GAMMA; KERATINOCYTES; NF-KAPPA B; PLANT EXTRACTS; PSIDIUM; STAT1 TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

PSIDIUM GUAJAVA;

EID: 80051600101     PISSN: 13826689     EISSN: 18727077     Source Type: Journal    
DOI: 10.1016/j.etap.2011.04.004     Document Type: Article

References (45)

1. Adcock I.M. Transcription factors as activators of gene transcription: AP-1 and NF-kappa B. Monaldi Arch. Chest. Dis. 1997, 52:178-186.
2. Breuer K., Werfel T., Kapp A. Allergic manifestations of skin diseases-atopic dermatitis. Chem. Immunol. Allergy 2006, 91:76-86.
3. Campbell J.J., Haraldsen G., Pan J., Rottman J., Qin S., Ponath P., Andrew D.P., Warnke R., Ruffing N., Kassam N., Wu L., Butcher E.C. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 1999, 400:776-780.
4. Furukawa H., Takahashi M., Nakamura K., Kaneko F. Effect of an antiallergic drug (Olopatadine hydrochloride) on TARC/CCL17 and MDC/CCL22 production by PBMCs from patients with atopic dermatitis. J. Dermatol. Sci. 2004, 36:165-172.
5. Godisk R., Chantry D., Raport C.J., Sozzani S., Allavena P., Leviten D., Mantovani A., Gray P.W. Human macrophage derived chemokine (MDC) a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells. J. Exp. Med. 1997, 185:1595-1604.
6. Gutiérrez R.M., Mitchell S., Solis R.V. Psidium guajava: a review of its traditional uses, phytochemistry and pharmacology. J. Ethnopharmacol. 2008, 117:1-27.
7. Han, E.H., Hwang, Y.P., Kim, H.G., Park, J.H., Choi, J.H., Im, J.H., Khanal, T., Park, B.H., Yang, J.H., Choi, J.M., Chun, S.S., Seo, J.K., Chung, Y.C., Jeong, H.G. Ethyl acetate extract of Psidium guajava inhibits IgE-mediated allergic responses by blocking Fce{open}RI signaling. Food Chem. Toxicol., in press, PMID: 21440028.
8. Hashimoto S., Nakamura K., Oyama N., Kaneko F., Tsunemi Y., Saeki H., Tamaki K. Macrophage-derived chemokine (MDC)/CCL22 produced by monocyte derived dendritic cells reflects the disease activity in patients with atopic dermatitis. J. Dermatol. Sci. 2006, 44:93-99.
9. Hino R., Kobayashi M., Mori T., Orimo H., Shimauchi T., Kabashima K., Tokura Y. Inhibition of T helper 2 chemokine production by narrowband ultraviolet B in cultured keratinocytes. Br. J. Dermatol. 2007, 156:830-837.
10. Hsieh C.L., Huang C.N., Lin Y.C., Peng R.Y. Molecular action mechanism against apoptosis by aqueous extract from guava budding leaves elucidated with human umbilical vein endothelial cell (HUVEC) model. J. Agric. Food Chem. 2007, 55:8523-8533.
11. Imai T., Yoshida T., Baba M., Nishimura M., Kakizaki M., Yoshie O. Molecular cloning of a novel T cell-directed CC chemokine expressed in thymus by signal sequence trap using Epstein-Barr virus vector. J. Biol. Chem. 1996, 271:21514-21521.
12. Ishikawa-Mochizuki I., Kitaura M., Baba M., Nakayama T., Izawa D., Imai T., Yamada H., Hieshima K., Suzuki R., Nomiyama H., Yoshie O. Molecular cloning of a novel CC chemokine interleukin-11 receptor a-locus chemokine (ILC), which is located on chromosome 9p13 and a potential homologue of a CC chemokine encoded by molluscum contagiosum virus. FEBS Lett. 1999, 460:544-548.
13. Iwu M.M. Handbook of African Medicinal Plants 1993, CRC Press, pp. 786-9.
14. Ju S.M., Song H.Y., Lee S.J., Seo W.Y., Sin D.H., Goh A.R., Kang Y.H., Kang I.J., Won M.H., Yi J.S., Kwon D.J., Bae Y.S., Choi S.Y., Park J. Suppression of thymus- and activation-regulated chemokine (TARC/CCL17) production by 1,2,3,4,6-penta-O-galloyl-beta-d-glucose via blockade of NF-kappaB and STAT1 activation in the HaCaT cells. Biochem. Biophys. Res. Commun. 2009, 387:115-120.
15. Kakinuma T., Saeki H., Tsunemi Y., Fujita H., Asano N., Mitsui H., Tada Y., Wakugawa M., Watanabe T., Torii H., Komine M., Asahina A., Nakamura K., Tamaki K. Increased serum cutaneous T cell-attracting chemokine (CCL27) levels in patients with atopic dermatitis and psoriasis vulgaris. J. Allergy Clin. Immunol. 2003, 111:592-597.
16. Kawai M., Hirano T., Higa S., Arimitsu J., Maruta M., Kuwahara Y., Ohkawara T., Hagihara K., Yamadori T., Shima Y., Ogata A., Kawase I., Tanaka T. Flavonoids and related compounds as anti-allergic substances. Allergol. Int. 2007, 56:113-123.
17. Kim J.S., Song H.J., Ko S.K., Whang W.K., Sohn U.D. Quercetin-3-O-[beta]-d-glucuronopyranoside (QGC)-induced HO-1 expression through ERK and PI3K activation in cultured feline esophageal epithelial cells. Fitoterapia 2010, 81:85-92.
18. Komine M., Kakinuma T., Kagami S., Hanakawa Y., Hashimoto K., Tamaki K. Mechanism of thymus- and activation-regulated chemokine (TARC)/CCL17 production and its modulation by roxithromycin. J. Invest. Dermatol. 2005, 125:491-498.
19. Kunkel E.J., Butcher E.C. Chemokines and the tissue-specific migration of lymphocytes. Immunity 2002, 16:1-4.
20. Lau A., Villeneuve N.F., Sun Z., Wong P.K., Zhang D.D. Dual roles of Nrf2 in cancer. Pharmacol. Res. 2008, 58:262-270.
21. Lee B.S., Shim S.M., Heo J., Pae H.O., Seo B.Y., Han S.Y., Sohn D.H., Jang S.I., Chung H.T. Wogonin suppresses TARC expression induced by mite antigen via heme oxygenase 1 in human keratinocytes. Suppressive effect of wogonin on mite antigen-induced TARC expression. J. Dermatol. Sci. 2007, 46:31-40.
22. Li J., Chen F., Luo J. GC-MS analysis of essential oil from the leaves of Psidium guajava. Zhong Yao Cai. 1999, 22:78-80.
23. Nakayama T., Hieshima K., Nagakubo D., Sato E., Nakayama M., Kawa K., Yoshie O. Selective induction of Th2-attracting chemokines CCL17 and CCL22 in human B cells by latent membrane protein 1 of Epstein-Barr virus. J. Virol. 2004, 78:1665-1674.
24. Nguyen T., Sherratt P.J., Pickett C.B. Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. Annu. Rev. Pharmacol. Toxicol. 2003, 43:233-260.
25. Nickel R., Beck L.A., Stellato C., Schleimer R.P. Chemokines and allergic diseases. J. Allergy Clin. Immunol. 1999, 104:723-742.
26. Oliver B.B. Medicinal Plants in tropical West Africa 1986, Cambridge University Press, Cambridge, pp. 457-61.
27. Pivarcsi A., Homey B. Chemokine networks in atopic dermatitis: traffic signals of disease. Curr. Allergy Asthma Rep. 2005, 5:284-290.
28. Qi X.F., Kim D.H., Yoon Y.S., Li J.H., Song S.B., Jin D., Huang X.Z., Teng Y.C., Lee K.J. The adenylyl cyclase-cAMP system suppresses TARC/CCL17 and MDC/CCL22 production through p38 MAPK and NF-kappaB in HaCaT keratinocytes. Mol. Immunol. 2009, 46:1925-1934.
29. Qian H., Nihorimbere V. Antioxidant power of phytochemicals from Psidium guajava leaf. J. Zhejiang Univ. Sci. 2004, 5:676-683.
30. Reiss Y., Proudfoot A.E., Power C.A., Campbell J.J., Butcher E.C. CC chemokine receptor (CCR) 4 and CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin. J. Exp. Med. 2001, 194:1541-1547.
31. Rudikoff D., Lebwohl M. Atopic dermatitis. Lancet 1998, 351:1715-1721.
32. Sallusto F., Schaerli P., Loetscher P., Schaniel C., Lenig D., Mackay C.R., Qin S., Lanzavecchia A. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur. J. Immunol. 1998, 28:2760-2769.
33. Sebastiani S., Albanesi C., De P.O., Puddu P., Cavani A., Girolomoni G. The role of chemokines in allergic contact dermatitis. Arch. Dermatol. Res. 2002, 293:552-559.
34. Sekiya T., Miyamasu M., Imanishi M., Yamada H., Nakajima T., Yamaguchi M., Fujisawa T., Pawankar R., Sano Y., Ohta K., Ishii A., Morita Y., Yamamoto K., Matsushima K., Yoshie O., Hirai K. Inducible expression of a Th2-type CC chemokine thymus and activation-regulated chemokine by human bronchial epithelial cells. J. Immunol. 2000, 165:2205-2213.
35. Seo N., Ito T., Wang N., Yao X., Tokura Y., Furukawa F., Takigawa M., Kinataka S. Anti-allergic Psidium guajava extracts exert an antitumor effect inhibition of T regulatory cells and resultant augmentation of Th1 cells. Anticancer Res. 2005, 25:3763-3770.
36. Shimada Y., Takehara K., Sato S. Both Th2 and Th1 chemokines (TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with atopic dermatitis. J. Dermatol. Sci. 2004, 34:201-208.
37. Tsukahara H., Shibata R., Ohshima Y., Todoroki Y., Sato S., Ohta N., Hiraoka M., Yoshida A., Nishima S., Mayumi M. Oxidative stress and altered antioxidant defenses in children with acute exacerbation of atopic dermatitis. Life Sci. 2003, 72:2509-2516.
38. Vestergaard C., Yoneyama H., Murai M., Nakamura K., Tamaki K., Terashima Y., Imai T., Yoshie O., Irimura T., Mizutani H., Matsushima K. Overexpression of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. J. Clin. Invest. 1999, 104:1097-1105.
39. Vestergaard C., Bang K., Gesser B., Yoneyama H., Matsushima K., Larsen C.G. A Th2 Chemokine, TARC, produced by keratinocytes may recruit CLA{thorn}CCR4{thorn} lymphocytes into lesional atopic dermatitis skin. J. Invest. Dermatol. 2000, 115:640-646.
40. Vestergaard C., Kirstejn N., Gesser B., Mortensen J.T., Matsushima K., Larsen C.G. IL-10 augments the IFN-gamma and TNF-alpha induced TARC production in HaCaT cells: a possible mechanism in the inflammatory reaction of atopic dermatitis. J. Dermatol. Sci. 2001, 26:46-54.
41. Weston, W.L., Howe, W., 2008. Epidemiology, clinical manifestations, and diagnosis of atopic dermatitis (eczema). UpToDate 2007. Available at: (accessed 16.06.08). http://www.uptodate.com/.
42. Yang G., Nguyen X., Ou J., Rekulapelli P., Stevenson D.K., Dennery P.A. Unique effects of zinc protoporphyrin on HO-1 induction and apoptosis. Blood 2001, 97:1306-1313.
43. Yu B., Koga T., Urabe K., Moroi Y., Maeda S., Yanagihara Y., Furue M. Differential regulation of thymus and activation-regulated chemokine induced by IL-4, IL-13, TNF-α and IFN-γ in human keratinocyte and fibroblast. J. Dermatol. Sci. 2002, 30:29-36.
44. Zheng X., Nakamura K., Tojo M., Oyama N., Nishibu A., Satoh M., Kakinuma T., Wakugawa M., Tamaki K., Kaneko F. TGF-beta1-mediated regulation of thymus and activation-regulated chemokine (TARC/CCL17) synthesis and secretion by HaCaT cells co-stimulated with TNF-alpha and IFN-gamma. J. Dermatol. Sci. 2002, 30:154-160.
45. Zuckerbraun B.S., Billiar T.R., Otterbein S.L., Kim P.K., Liu F., Choi A.M., Bach F.H., Otterbein L.E. Carbon monoxide protects against liver failure through nitric oxide-induced heme oxygenase 1. J. Exp. Med. 2003, 198:1707-1716.